[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-345212-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-345212-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","mct4-deficiency-suppresses-tumor-incidence-and-metastasis-by-downregulating-igf1-expression-and-enhancing-anti-tumor-immunity","MCT4 deﬁciency suppresses tumor incidence and metastasis by downregulating IGF1 expression and enhancing anti-tumor immunity","","Monocarboxylate transporter 4 (MCT4/SLC16A3) is frequently upregulated in human cancers and linked to aggressive progression and poor outcomes. Using CRISPR/Cas9-EGE technology, researchers generated MCT4 homozygous knockout BALB/c mice and found ~40% reductions in allograft tumor volume. Decreased circulating and tumor interstitial IGF1 (by 40–45%) partially explains tumor suppression, and exogenous IGF1 restores growth. MCT4 loss also boosts antitumor immunity with increased CD4+ and CD8+ T cells, NK cells, and macrophages, shifting M2 to pro-inflammatory M1 macrophages, reducing lesion burden across multiple carcinogenesis models.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/mct4-deficiency-suppresses-tumor-incidence-and-metastasis-by-downregulating-igf1-expression-and-enhancing-anti-tumor-immunity/345212/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/mct4-deficiency-suppresses-tumor-incidence-and-metastasis-by-downregulating-igf1-expression-and-enhancing-anti-tumor-immunity/345212.png","ImageObject",300,407,{"name":42,"@type":43},"Aria","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How does MCT4 deficiency affect tumor incidence and metastasis?","Question",{"text":63,"@type":64},"MCT4 homozygous knockout mice develop fewer and smaller lesions and show reduced allograft tumor volume, indicating suppressed tumor incidence and metastatic potential.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What role does IGF1 play in the tumor-suppressing effect of MCT4 loss?",{"text":68,"@type":64},"MCT4 deficiency diminishes circulating and tumor interstitial IGF1 levels by about 40–45%, and providing exogenous IGF1 restores tumor growth, confirming dependency.",{"name":70,"@type":61,"acceptedAnswer":71},"How does MCT4 deficiency alter antitumor immunity in the tumor microenvironment?",{"text":72,"@type":64},"Loss of MCT4 increases infiltration of CD4+ and CD8+ T cells, NK cells, and macrophages, and drives macrophage polarization from immunosuppressive M2 toward pro-inflammatory M1 states.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},345212,1790581741,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","communications biology Article  \nA Nature Portfolio journal  \n[https://doi.org/10.1038/s42003-026-10002-8](https://doi.org/10.1038/s42003-026-10002-8)  \nMCT4 deﬁciency suppresses tumor incidence and metastasis by downregulating IGF1 expression and enhancing anti-tumor immunity  \n Check for updates  \n\n| Shuo Wang 1, Hailing Guo1, Lujin Feng1, Xinyi Wang1, Yujie Zhang1, Xin Li1, Xiaoju Zhou 2  & Ningning Ma 1  |  |\n| --- | --- |\n| Monocarboxylate transporter 4 (MCT4/SLC16A3) is frequently upregulated in human cancers and associated with aggressive progression and poor clinical outcomes. To elucidate its functional role, we establish MCT4 homozygous knockout BALB/c mice (MCT4-/-) using CRISPR/Cas9-EGE technology. Compared with wild-type counterparts, MCT4-/- mice exhibit ~40% reduction in allograft tumor volume, which is partly attributable to diminished IGF1 production, as circulating and tumor interstitial IGF1levels decrease by40–45%. Exogenous IGF1supplementation restores tumor growth, conﬁrming this dependency. Moreover, MCT4 deﬁciency enhances antitumor immunity, characterized by increased inﬁltration of CD4⁺ and CD8⁺ T cells, NK cells, and macrophages, with a pronounced shift from immunosuppressive M2 to pro-inﬂammatory M1 macrophages. Consistently, across three independent carcinogenesis models(breast, lung, oralsquamous cancers), MCT4-/-mice develop fewer and smaller lesions, underscoring its critical role in tumor incidence. Collectively, these ﬁndings identify MCT4 as a key driver of carcinogenesis through IGF1 regulation and immune modulation, highlighting its therapeutic potential. |  |\n| Highly proliferative cells, including cancerous, embryonic, activated immune, and regenerating tissue cells, preferentially use glycolysis as a primary energy-producing process, leading to the production of a large quantity of lactate as the end product1,2. Tumor cells in the tumor microenvironment (TME) have limited oxygen supply, but even with ample oxygen supply, highly proliferating tumor cells preferentially rely on glycolysis for energy production, a phenomenon widely known as the “Warburg effect”3,4. Although the amount of adenosine triphosphate (ATP) generated by glycolysis is signiﬁcantly lower than that produced by oxidative phosphorylation for each glucose molecule, the metabolic ﬂow through the glycolytic pathway, and hence the rate of ATP generation, is much faster, which better suits the high energy demands of rapidly proliferating tumor cells1. As glycolytic intermediates are essential raw materials for the synthesis of cellular biomacromolecules, the Warburg effect beneﬁts cancer cells in bioenergetics and biosynthesis5.\u003Cbr>To avoid intracellular acidiﬁcation, cancer cells upregulate the expression of monocarboxylate transporters (MCTs) to export lactate into the TME6–8. MCT1 (encoded by SLC16A1)serves asbotha lactate importer | and exporter, whereas MCT4 (encoded by SLC16A3) serves primarily as a lactate exporter, even against high lactate concentrations in the TME9, 10. Under physiological conditions, MCT4 expression is primarily limited to highly glycolytic tissues, such as the skeletal muscle, and astrocytes11. Overexpression of MCT1 and MCT4 has been reported in various cancers, including breast, colon, pancreatic, and prostate cancers; glioblastoma; and renal cell carcinoma12. Upregulated MCT1 and MCT4 expression is strongly correlated with metastasis and poor prognosis in patients with cancer13–16. Inhibitors to MCT1 and/or MCT4 have shown promise for cancer therapy17, 18; however, no therapeutics have yet been approved19.\u003Cbr>The molecular mechanisms of MCT in tumorigenesis and progression remain elusive. We previously expressed MCT1 and MCT4 in nononcogenic L929 cells and demonstrated that overexpression of MCT4, but not MCT1, enhanced the migration and invasion of non-oncogenic L929 ﬁbroblasts20. Furthermore, we identiﬁed that MCT4 promotes cell migration by upregulating the expression of insulin-like growth","cbCailir51VqxNp1","https://ap.wps.com/l/cbCailir51VqxNp1","pdf",3216400,14,"English","# Background\n## Glycolysis, lactate export, and the Warburg effect\n## MCT4 and IGF1 in tumor progression\n# Methods\n## CRISPR/Cas9 generation of MCT4 knockout mice\n## In vivo validation across models\n## Immune profiling in the tumor microenvironment\n# Results\n## Reduced tumor growth via IGF1 downregulation\n## Restored growth with exogenous IGF1\n## Enhanced immune infiltration and M1/M2 shift\n# Conclusion\n## MCT4 as a driver through IGF1 regulation and immune modulation","[{\"question\":\"How does MCT4 deficiency affect tumor incidence and metastasis?\",\"answer\":\"MCT4 homozygous knockout mice develop fewer and smaller lesions and show reduced allograft tumor volume, indicating suppressed tumor incidence and metastatic potential.\"},{\"question\":\"What role does IGF1 play in the tumor-suppressing effect of MCT4 loss?\",\"answer\":\"MCT4 deficiency diminishes circulating and tumor interstitial IGF1 levels by about 40–45%, and providing exogenous IGF1 restores tumor growth, confirming dependency.\"},{\"question\":\"How does MCT4 deficiency alter antitumor immunity in the tumor microenvironment?\",\"answer\":\"Loss of MCT4 increases infiltration of CD4+ and CD8+ T cells, NK cells, and macrophages, and drives macrophage polarization from immunosuppressive M2 toward pro-inflammatory M1 states.\"}]","MCT4 deﬁciency suppresses tumor incidence and metastasis by downregulating IGF1 expression and enhancing anti-tumor immunity | PDF",1790056811,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c496adafd06c21bd3aa57e8eca3fc9f9.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5b918e397d254d087b0d766a96d6c107.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6fa1f654bf1bc4e125819142a3d3f4e6.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1bf5ea256172b0776ea993d799f408d8.webp",980,1301]